Liao et al. demonstrated that GPR39 inhibited AMPK signaling with mTOR and S6k1 activation, which induced the activation of de novo protein synthesis, leading to cardiac hypertrophy in mice. The gene discussed is GPR39; the disease is cardiac hypertrophy.